# Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

> **NCT06252662** · PHASE4 · RECRUITING · sponsor: **United States Naval Medical Center, Portsmouth** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Liposomal bupivacaine

## Key facts

- **NCT ID:** NCT06252662
- **Lead sponsor:** United States Naval Medical Center, Portsmouth
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2025-07
- **Final completion:** 2025-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06252662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06252662, "Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06252662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*